Skip to main content

Travere Therapeutics, Inc 10-Q for FY2026 Q1

Travere Therapeutics, Inc. (TVTX)

10-Q 2026-05-04 For: 2026-03-31
View Original
Added on May 04, 2026

About this 10-Q

Travere Therapeutics, Inc filed this 10-Q on May 4, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).

Headline figures

Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$127.2M
up 55.6% from $81.73M a year earlier
Net loss
$37.1M
compared with a net loss of $41.23M a year earlier
Diluted EPS
-$0.40
compared with -$0.47 a year earlier